Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Frontiers in Physiology Année : 2021

Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach

Justine Frija-Masson
  • Fonction : Auteur
Catherine Bancal
  • Fonction : Auteur
Laurent Plantier
  • Fonction : Auteur
Hélène Benzaquen
  • Fonction : Auteur
Florence Arnoult
  • Fonction : Auteur
Martin Flamant
  • Fonction : Auteur
Marie-Pia D’ortho
  • Fonction : Auteur

Résumé

Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV - 2 ) infection has affected millions of people worldwide, and pneumonia affects 90% of patients. This raises the possibility of millions of people with altered lung function. Few data exist to date on pulmonary function after SARS-CoV-2 infection, but alteration of diffusion capacity of CO ( D LCO ) is the most frequently described abnormality. First, we present original data on lung function at 3 months after SARS-CoV-2 infection and discuss the effect of using European Coal and Steel Community (ECSC) or Global Lung Function Initiative (GLI) reference equations to diagnose diffusion capacity. Second, we review existing data on D LCO alteration after SARS-CoV-2 infection and discuss the implication of restrictive disorder in D LCO alteration. Last, we discuss the pathophysiology of D LCO alteration and try to disentangle vascular damage and fibrosis.

Dates et versions

hal-04078463 , version 1 (23-04-2023)

Identifiants

Citer

Justine Frija-Masson, Catherine Bancal, Laurent Plantier, Hélène Benzaquen, Laurence Mangin, et al.. Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach. Frontiers in Physiology, 2021, 12, ⟨10.3389/fphys.2021.624062⟩. ⟨hal-04078463⟩
14 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More